FDA Letter API

Leaf of Life LLC

Letter data

Company
Leaf of Life LLC
Recipient
Michael A. Bolan | Owner | Leaf of Life LLC | 12355 Country Glen Lane | Creve Coeur | , | MO | 63141 | United States
Issue date
2023-01-18
Posted date
Not available
FDA office
Office of Human and Animal Food- West Division II
Subject
Not available
Product
Dietary Supplements
CMS ID
619191
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Leaf of Life LLC MARCS-CMS 619191 — January 18, 2023 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UPS Product: Dietary Supplements Recipient: Recipient Name Michael A. Bolan Recipient Title Owner Leaf of Life LLC 12355 Country Glen Lane Creve Coeur , MO 63141 United States Issuing Office: Office of Human and Animal Food- West Division II United States Dear Mr. Bolan, The Food and Drug Administration has completed an evaluation of Leaf of Life LLC corrective actions in response to our Warning Letter (CMS case # 619191 dated August 4, 2022) during our investigation conducted on October 27, 2022. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ LaTonya M. Mitchell, Ph.D. Program Division Director Office of Human and Animal Foods-West Division 2 Content current as of: 01/23/2023 Regulated Product(s) Dietary Supplements